ENETS Consensus Guidelines Neuroendocrinology 2012;95:120–134 DOI: Published online: February 15, 2012

First Page		Document Content
Date: 2012-08-30 10:04:38 Neuroendocrine tumor Pancreatic cancer Hepatology Kidney cancer Pancreatectomy Carcinoid Renal cell carcinoma Pheochromocytoma Pituitary adenoma Medicine Oncology Pancreas disorders		ENETS Consensus Guidelines Neuroendocrinology 2012;95:120–134 DOI: Published online: February 15, 2012 Add to Reading List Source URL: www.enets.org Download Document from Source Website File Size: 830,82 KB Share Document on Facebook

	“New Paradigms That Increase Survival in Neuroendocrine Tumor Patients” Eugene A. Woltering MD FACS NOLANETSZEBRA = office DocID: 1v5gL - View Document
	ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D DocID: 1rlNJ - View Document
	J. Vet. Med. A 36, 1989 Paul Parey Scientific Publishers, Berlin and Hamburg ISSN184X Department of Veterinary Pathology2, University of Utrecht, The Netherlands, Department of Veterinary Patholo DocID: 1r81K - View Document
	ORIGINAL ARTICLE Validation of Neurokinin A Assays in the United States and Europe Paris Mamikunian,* Joy E. Ardill, PhD,Þ Thomas M. O’Dorisio, MD,þ Siegfried R. Krutzik, PhD,* Aaron I. Vinik, MD, PhD,§ Vay Liang W DocID: 1r2MN - View Document
	JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide DocID: 1qMJM - View Document